China’s Qiming Ventures leads $37m funding in AlphaBio Biopharma

AlphaBio Qiming Venture Partners
Visual from Alpha Biopharma's website.

Chinese venture capital firm Qiming Venture Partners took the lead in the $37-million first close of Shanghai-based biopharmaceutical firm Alpha Biopharma (AlphaBio)’s Series A financing.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Should your colleagues be reading this article too? Contact us for corporate subscriptions at subs@dealstreetasia.com.